Search Results for ''

published presentations and documents on DocSlides.

PCSK9 Inhibition: LDL Lowering

PCSK9 Inhibition: LDL Lowering

by SweetiePie

PCSK9 inhibitors. New option for dyslipidemia. Ali...

LDL-CHOLESTEROL Presented By

LDL-CHOLESTEROL Presented By

by williams

Assist.Lecturer. Aseel. . Ghassan. . Daoud. M.Sc...

LDL is causal of atherosclerosis

LDL is causal of atherosclerosis

by morgan

Evidence from . meta-analyses of . Mendelian. . r...

Is lower better? LDL targets and beyond.

Is lower better? LDL targets and beyond.

by olivia-moreira

Implications of the relationship between risk fac...

Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?

Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?

by min-jolicoeur

NICE –CG 181 Continuum of CVD Risk and its trea...

Is lower better? LDL targets and beyond.

Is lower better? LDL targets and beyond.

by trish-goza

Implications of the relationship between risk fac...

Residual risk: Is LDL target enough?

Residual risk: Is LDL target enough?

by candy

An interpretation of the continuous relationship b...

Risk factors in heart disease

Risk factors in heart disease

by faustina-dinatale

Optimizing . patient care. William Cromwell, MD, ...

Triglycerides and Risk for Atherothrombosis

Triglycerides and Risk for Atherothrombosis

by briana-ranney

Thomas Dayspring, MD, FACP. Clinical Assistant Pr...

Residual risk and HDL-cholesterol:

Residual risk and HDL-cholesterol:

by bitsy

What are the current perspectives?. Prof. . Erik ....

New concepts and guidelines in the management of LDL-c and CV Risk:

New concepts and guidelines in the management of LDL-c and CV Risk:

by cappi

Need for early intervention. Prof. . Ulf . Landmes...

D yslipidemia Objectives :

D yslipidemia Objectives :

by arya

Know the clinical terminology for . dyslipidemia...

DYSLIPIDEMIA IN DIABETES

DYSLIPIDEMIA IN DIABETES

by esther

MAHTAB NIROOMAND M.D.. Assistant professor of End...

The New Cholesterol Guidelines:

The New Cholesterol Guidelines:

by lily

Beauty is in the Eye of the Beholder. Brian Asbill...

Rational Order of Laboratory Tests in Cardiovascular Diseases

Rational Order of Laboratory Tests in Cardiovascular Diseases

by carneos

Sedighe. . S. adat . Ghorashi. . MD. Family Medic...

Management of Common Comorbidities in Diabetes

Management of Common Comorbidities in Diabetes

by celsa-spraggs

1. Obesity. Management of Common Comorbidities in...

The Importance of Potential

The Importance of Potential

by pamella-moone

Statin. in High Risk Patient. Masrul Syafri. Bag...

Cholesterol-Lowering Drugs

Cholesterol-Lowering Drugs

by cheryl-pisano

Victor Nadler. Objectives. By the end of this cla...

Update: Lipid Guidelines

Update: Lipid Guidelines

by yoshiko-marsland

DO NOT BURN THE COOKIES. Amy R. Woods, M.D.. a. ...

American Association of Clinical Endocrinologists and American College of Endocrinology

American Association of Clinical Endocrinologists and American College of Endocrinology

by natalia-silvester

Guidelines for Management of Dyslipidemia . and P...

협심증 ( 狹心症 )

by lois-ondreau

Kyung Woo Park, MD, PhD, MBA . Seoul National Uni...

Understanding Blood Lipids

Understanding Blood Lipids

by myesha-ticknor

and Their Relationship to Health. Mark Pettus MD...

Hypertension & Cholesterol

Hypertension & Cholesterol

by cheryl-pisano

Blake Wachter, MD, PhD. Idaho Heart Institute. Ep...

Protecting the heart and the kidney:

Protecting the heart and the kidney:

by marina-yarberry

Implications from the SHARP trial. Dr. Christina ...

by olivia-moreira

Dyslipidemia. . Treatment. USA-145-101385. © . ...

Disorders of Lipid Metabolism

Disorders of Lipid Metabolism

by abigail

Dr. . Haidar. F. Al-. Rubaye. . Lipids are an e...

SWL lipid management guideline update- Highlights

SWL lipid management guideline update- Highlights

by finley

. Pedro Bandeira. Specialist Pharmacist- Cardiov...

Dyslipidemia (Med-3) Dr Anwar A Jammah

Dyslipidemia (Med-3) Dr Anwar A Jammah

by bety

, MD, FRCPC, FACP, CCD, ECNU.. Associate . Profess...

CardioMetabolic Wellness

CardioMetabolic Wellness

by osullivan

Gary E. Foresman, MD. January 2019. What Is Middle...

Non-obese rheumatoid arthritis patients

Non-obese rheumatoid arthritis patients

by valerie

withlow. low-density lipoprotein have higher coro...

Dyslipidemia (Med-341) Dr Anwar A Jammah

Dyslipidemia (Med-341) Dr Anwar A Jammah

by sophia2

, MD, FRCPC, FACP, CCD, ECNU.. Asst. Professor and...

In the Name of God Management

In the Name of God Management

by genevieve

of. Dyslipidemia. Navid Saadat, MD. Associate Pro...

Treatment of Blood Cholesterol

Treatment of Blood Cholesterol

by daniella

to Reduce Atherosclerotic Cardiovascular . Risk in...

THE MANAGEMENT OF DYSLIPIDEMIA Updated Version 20 150 2006

THE MANAGEMENT OF DYSLIPIDEMIA Updated Version 20 150 2006

by ariel

VA/DoD Clinical Practice Guideline Introduction ...

CLINICAL PRACTICE

CLINICAL PRACTICE

by mia

USTRALIAN FAMILY Vol. 37, No. 7, July 2008 ichard ...

Management of Dyslipidaemia

Management of Dyslipidaemia

by anderson

July 2017 Edition of Clinical Practice Guidelines ...

6701 Carnegie Ave Suite 500 Cleveland OH 44103 p 8663589828

6701 Carnegie Ave Suite 500 Cleveland OH 44103 p 8663589828

by gelbero

ApoE genotype can affect:Response to treatment wit...

In The Name Of God Dyslipidemia

In The Name Of God Dyslipidemia

by PinkPandaBear

/Lipid management in . Diabetes. Dr.Zahra. . davo...

Lipid Treatment Updates in Management

Lipid Treatment Updates in Management

by TheCookieMonster

Debra Griner, MS FNP-C. Mesa Primary Care. Casper,...

D yslipidemia DR,DUAA HIASAT

D yslipidemia DR,DUAA HIASAT

by mackenzie

Objectives :. Know the clinical terminology for ...